Runatek announces an aggressive plan to prepare the company for a round of fundraising
Updated: Feb 10
DALLAS, TX. – Runatek announces an aggressive plan to prepare the company for a round of fundraising.
In January 2021, members of the Board of Directors approved a plan dubbed “Operation Cannonball” to rapidly advance the development of the company in preparation for a round of financing through crowdfunding. This will be the first outside capital raise for the company, and will utilize the funds raised for product development through the FDA approval process.
Key components of Operation Cannonball involve corporate restructuring, rapid business development, and a two-month timeline to produce a functional demonstration prototype as a proof of concept ahead of the raise round. The Board of Directors is very enthusiastic about this plan, and are “certain that these next two months represent a critical period for the company, as we grow and bring in outside investment.”